Literature DB >> 19200575

Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland.

Jespal Gill1, Neville Angelo, Mee Ling Yeong, Nick McIvor.   

Abstract

Hyper IgG4 disease or IgG4-related sclerosing/autoimmune disease is a multisystem condition characterized histologically by fibrosis, lymphoplasmacytic infiltration, and abundant IgG4 plasma cells associated with raised serum IgG4 levels. We present a case of salivary duct carcinoma of the parotid gland in a background of chronic sclerosing sialadenitis that also involved the submandibular gland with associated regional lymphadenopathy. The serology showed raised total IgG levels of 16.3 g/L (reference range, 6.0-15.0) and raised IgG4 levels of 3.41 g/L (reference range, 0.07-1.70). The salivary duct carcinoma contained areas of dense fibrosis and abundant IgG4-positive plasma cells (>100 per high-power field [hpf]). The adjacent noncarcinomatous areas, submandibular gland, and regional lymph nodes also contained plasma cells immunoreactive to IgG4 with densities higher than 100/hpf. To the best of our knowledge, this case is the first documentation of malignancy occurring in a background of IgG4-related autoimmune disease of the salivary gland.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200575     DOI: 10.1016/j.humpath.2008.10.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

Review 1.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

2.  IgG4-associated cholangitis with cholangiocarcinoma.

Authors:  Beate K Straub; Irene Esposito; Daniel Gotthardt; Boris Radeleff; Dalibor Antolovic; Christa Flechtenmacher; Peter Schirmacher
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

Review 3.  [Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations].

Authors:  A Agaimy; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

Review 4.  Immunoglobulin G4-Related Thyroid Diseases.

Authors:  Dulani Kottahachchi; Duncan J Topliss
Journal:  Eur Thyroid J       Date:  2016-12-03

5.  A case of IgG4-related disease associated with diffuse large B cell lymphoma.

Authors:  Toshiyuki Mitsuyama; Akiyoshi Nishio; Makoto Takaoka; Kazushige Uchida; Masaaki Shimatani; Toshiro Fukui; Tsukasa Ikeura; Masaki Koyabu; Hideaki Miyoshi; Takeo Kusuda; Akiko Kurishima; Yuri Fukui; Kimi Sumimoto; Shinya Fujita; Yoshiko Uemura; Kazuichi Okazaki
Journal:  Clin J Gastroenterol       Date:  2012-11-27

Review 6.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

7.  Immunoglobulin G4-related autoimmune pancreatitis and sialadenitis: A case report.

Authors:  Ru-Ying Fan; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  Synchronous occurrence of IgG4-related sialadenitis and ductal carcinoma of the parotid gland: a case report.

Authors:  Angel Rollon-Mayordomo; Ana Avellaneda-Camarena; Alvaro Gutierrez-Domingo; Elena Martinez-Carapeto; Pedro Infante-Cossio
Journal:  Gland Surg       Date:  2021-06

Review 9.  IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

Authors:  Mukul Divatia; Sun A Kim; Jae Y Ro
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

Review 10.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Takayuki Sumida; Tsuneyo Mimori; Yoshiya Tanaka; Kazuo Tsubota; Tadashi Yoshino; Shigeyuki Kawa; Ritsuro Suzuki; Tsutomu Takegami; Naohisa Tomosugi; Nozomu Kurose; Yasuhito Ishigaki; Atsushi Azumi; Masaru Kojima; Shigeo Nakamura; Dai Inoue
Journal:  Mod Rheumatol       Date:  2011-09-01       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.